Literature DB >> 8858741

Seroprevalence of Helicobacter pylori infection in medical staff in Shanghai.

W Z Liu1, S D Xiao, S J Jiang, R R Li, Z J Pang.   

Abstract

BACKGROUND: The epidemiology of Helicobacter pylori is still under investigation. It is postulated that the human stomach is the natural reservoir and that spread occurs by oral-oral or fecal-oral transmission. The aim of this study was to determine whether medical staff, especially endoscopy unit personnel, are at an increased risk of acquiring H. pylori infection.
METHODS: An enzyme-linked immunosorbent assay technique was used to detect circulating H. pylori IgG antibodies in 1050 medical staff from 16 hospitals in Shanghai, including 125 GI endoscopists, 45 endoscopy unit nurses, 71 gastroenterologists not doing endoscopy, 105 nurses working in gastroenterology wards, 417 internists, and 287 general nurses. This group was compared with an age-matched population obtained from the same urban area of the city.
RESULTS: The overall prevalence of H. pylori infection in total medical staff was 70.0%, compared to 44.6% in general population (P < 0.0001). Age-adjusted comparisons between subgroups of medical staff were made. The prevalence of H. pylori in GI endoscopists was 82.4%, which is significantly higher than 66.4% in internists and 65.8% in general nurses (all, P < 0.01) but not significantly different from 77.7% in endoscopy unit nurses or from 74.2% in nurses working in gastroenterology wards (all, P > 0.05). Further analysis did not show any significant difference in the prevalence of H. pylori between other subgroups. The prevalence of H. pylori infection in GI endoscopists increased with the number of years of practice.
CONCLUSIONS: Medical staff, especially endoscopy unit personnel, are at increased risk of infection with H. pylori. These findings strongly suggest the medical practice and endoscopy procedures are risk factors for H. pylori infection and support person-to-person transmission in this setting, probably from patients to medical staff.

Entities:  

Mesh:

Year:  1996        PMID: 8858741     DOI: 10.3109/00365529609010346

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

Review 1.  Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy.

Authors:  Douglas B Nelson; Lawrence F Muscarella
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

Review 2.  The occupational risk of Helicobacter pylori infection: a systematic review.

Authors:  Hassan Kheyre; Samantha Morais; Ana Ferro; Ana Rute Costa; Pedro Norton; Nuno Lunet; Bárbara Peleteiro
Journal:  Int Arch Occup Environ Health       Date:  2018-05-29       Impact factor: 3.015

Review 3.  Current status of basic and clinical research in the field of gastroenterology in China.

Authors:  X N Wu
Journal:  World J Gastroenterol       Date:  1997-03-15       Impact factor: 5.742

4.  Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation.

Authors:  Hong Ren; Ning Du; Gang Liu; Heng-Tong Hu; Wei Tian; Zhi-Ping Deng; Jing-Sen Shi
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

5.  Virulence of water-induced coccoid Helicobacter pylori and its experimental infection in mice.

Authors:  Fei-Fei She; Jian-Yin Lin; Jun-Yan Liu; Cheng Huang; Dong-Hui Su
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

6.  The occupational risk of Helicobacter pylori infection among gastroenterologists and their assistants.

Authors:  Claudia Peters; Anja Schablon; Melanie Harling; Claudia Wohlert; José Torres Costa; Albert Nienhaus
Journal:  BMC Infect Dis       Date:  2011-05-31       Impact factor: 3.090

7.  Does hospital work constitute a risk factor for Helicobacter pylori infection?

Authors:  P Mastromarino; C Conti; K Donato; P M Strappini; M S Cattaruzza; G B Orsi
Journal:  J Hosp Infect       Date:  2005-07       Impact factor: 3.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.